Detalhe da pesquisa
1.
Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD).
Clin Lung Cancer
; 22(6): 601-606, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34389237
2.
Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults.
Hum Vaccin Immunother
; 14(5): 1161-1174, 2018 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601256
3.
Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial.
Vaccine
; 35(16): 2052-2059, 2017 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28318767
4.
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial.
Vaccine
; 35(28): 3548-3557, 2017 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533054